Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
67
days
Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study)
AuthorsThibault de la Motte Rouge; Clémentine Vabre; Hélène Denis; Ester Alessandrini; Ludiane Gauthier; Aurélie Schmidt; Gaëlle Nachbaur; Florence Joly
AffiliationsCentre Eugène Marquis, Rennes, France; HEVA, Lyon, France; GSK France, 23, Rue François Jacob, 92500 Rueil-Malmaison, France; Centre François Baclesse, Caen, France; GINECO, Paris, France
103
days
Attractiveness of the clinical hematology specialty in France: A cross-sectional perspective from medical students, residents, and practicing hematologists
AuthorsLaurence Legros; Sylvain Choquet; Emmanuel Gyan; Roch Houot; Jean Christophe Ianotto
AffiliationsService d’hématologie clinique, hôpital Bicêtre, AP–HP, Paris, France; Inserm 1287, Institut Gustave-Roussy, Villejuif, France; Service d’hématologie clinique, groupe hospitalier Pitié-Salpêtrière, AP–HP, Sorbonne Université, Paris, France; Service d’hématologie, hôpital Bretonneau, CHRU de Tours, Tours, France; Service d’hématologie, CHU Rennes, Rennes, France; UMR U1236, Inserm, université de Rennes, Rennes, France; Service d’hématologie clinique, CHRU de Brest, Brest, France
294
days
Metabolic and cardiovascular disorders with lorlatinib: How to detect and manage them in practice?
AuthorsJennifer Arrondeau; Stéphane Ederhy; Christophe Héron; Benoit Blanchet; Virginie Avrillon; Chloé Levenbruck; Hervé Lena; Alexis Cortot
AffiliationsDepartment of Medical Oncology, Cochin Hospital, Paris, France; Département de pharmacologie, centre d’investigation clinique Paris-EST CIC-1901/Inserm, hôpital Pitié-Salpêtrière, Sorbonne université, Paris, France; Department of Nutrition, University Hospital, Lille, France; Drug Biology and Toxicology Service, Cochin Hospital Port-Royal, Public Assistance–Hospitals of Paris (AP–HP), Paris, France; Department of Medical Oncology, Léon-Bérard Center (CLB), Lyon cedex 08, France; Pharmacy Service, Sainte-Catherine Avignon-Provence Cancer Institute (ICAP), Avignon, France; Department of Pneumology, University Hospital, Rennes, France; Inserm, Department of Pneumology and Thoracic Oncology, CNRS, Institut Pasteur de Lille, UMR9020 – UMR1277 – Canther, Lille University Hospital, University of Lille, 59000 Lille, France
146
days
Cardiovascular toxicities of major oral targeted therapies used in solid tumor
AuthorsSimon Nannini; Clément Droesch; Emilie Schultz; Fabien Moinard-Butot
AffiliationsService d’oncologie médicale, institut Jules Bordet, université Libre de Bruxelles, 1070 Bruxelles, Belgique; Service de cardiologie, centre hospitalier universitaire de Saint-Étienne, 42770 Saint-Priest-en-Jarez, France; Service d’oncologie médicale, hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France
231
days
Experience and access to acupuncture in patients undergoing anticancer treatment: A multicentric cross-sectional cohort study
AuthorsFanny Adda; Guillaume Klausner; Jemie Reghdi; Eliane Tang; Christophe Tournigand; Natividad Alarcon; Yakouba Grichi; Carolina Saldana; Coralie Boiteau; Amina Bouras; Tâm Nhan; Emmanuelle Kempf
AffiliationsDépartement d’oncologie médicale, groupe hospitalo-universitaire Henri-Mondor et Albert-Chenevier, Assistance publique–Hôpitaux de Paris, université Paris Est Créteil, 1, rue Gustave-Eiffel, 94000 Créteil, France; Centre de haute énergie (CHE), 10, boulevard Pasteur, 06000 Nice, France; Centre Charlebourg – La Défense – Amethyst Radiothérapie, 65, avenue Foch, 92250 La Garenne-Colombes, France; Département de médecine interne, groupe hospitalo-universitaire Pitié-Salpêtrière, Assistance publique–Hôpitaux de Paris, université Paris Sorbonne, 47–83, boulevard de l’Hôpital, 75013 Paris, France
69
days
Analysis of treatment practices for locally advanced head and neck squamous cell carcinoma: A survey from GORTEC
AuthorsAlizée Simon; Hugo Charles; Jean Bourhis; Yoann Pointreau
AffiliationsOncologie médicale, institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54519 Vandœuvre-les-Nancy, France; Biostatistiques, Groupe d’oncologie radiothérapie tête et cou (GORTEC), 4, bis rue Emile-Zola, 37000 Tours, France; CHUV, bâtiment hospitalier, rue du Bugnon 21, 1011 Lausanne, Suisse; Oncologie radiothérapie, Institut inter-régionaL de cancérologie, centre Jean-Bernard au sein du centre de cancérologie de la Sarthe, clinique Victor-Hugo, 64, rue de degré, 72000 Le Mans, France
160
days
Low-dose screening for bronchopulmonary cancer: A general practitioner's perspective
AuthorsElodie Poupin; Yohann Hays; Gael Freche; Bernard Freche
AffiliationsDépartement de médecine générale, université de Poitiers, 6, rue de la Milétrie, 86073 Poitiers, France; Pôle de recherche en soins primaires, université de Poitiers, 6, rue de la Milétrie, 86073 Poitiers, France; Service de radiologie, hôpital Cochin, AP–HP, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France; Pôle biologie santé, Inserm 1070U, université de Poitiers, bâtiment B361 rue Georges-Bonnet, 86022 Poitiers cedex, France
154
days
PD-L1 expression in squamous cell carcinomas of the upper aerodigestive tract: Pathological challenges and therapeutic implications
AuthorsJérémie Ménager; Christol Fabre; Hugo Gil; Christian Righini
AffiliationsService d’anatomopathologie, CHU de Grenoble-Alpes, Grenoble, France; Service d’ORL, CHU de Grenoble-Alpes, Grenoble, France
197
days
Summary of second-line treatment of stage IV NSCLC without oncogenic addiction
AuthorsThomas Pierret; Renaud Descourt; Romain Corre; Pascale Tomasini; Chantal Decroisette
AffiliationsPneumologie, hôpital Louis-Pradel, hospices civils de Lyon, Lyon, France; Oncologie médicale, CHRU Morvan, Brest, France; Pneumologie, CH Cornouaille, Quimper, France; Innovations thérapeutiques et oncologie pluridisciplinaire, Assistance publique–Hôpitaux de Marseille, 13015 Marseille, France; Oncologie thoracique, centre Léon-Bérard, Lyon, France
113
days
Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration
AuthorsLila Philipps; Léo Mas; Thomas Samaille; Thierry André; Benoît Blanchet; Romain Cohen
AffiliationsSorbonne University, Department of Medical Oncology, hôpital Saint-Antoine, AP–HP, Paris, France; Inserm UMRS 938, équipe instabilité des microsatellites et cancer, équipe labellisée par la Ligue nationale contre le cancer, SIRIC CURAMUS, centre de recherche Saint-Antoine, Sorbonne University, Paris, France; Biologie du médicament-toxicologie, institut du cancer Paris CARPEM, centre université Paris Cité, hôpital Cochin, AP–HP, Paris, France
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days